Articles with public access mandates - Anna AzarovaLearn more
Available somewhere: 3
Emerging importance of ALK in neuroblastoma
AM Azarova, G Gautam, RE George
Seminars in cancer biology 21 (4), 267-275, 2011
Mandates: US National Institutes of Health
Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma
NF Moore, AM Azarova, N Bhatnagar, KN Ross, LE Drake, S Frumm, ...
Oncotarget 5 (18), 8737, 2014
Mandates: US National Institutes of Health
Genistein induces topoisomerase IIbeta-and proteasome-mediated DNA sequence rearrangements: Implications in infant leukemia
AM Azarova, RK Lin, YC Tsai, LF Liu, CP Lin, YL Lyu
Biochemical and biophysical research communications 399 (1), 66-71, 2010
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program